You have free access to this content

British Journal of Clinical Pharmacology

Cover image for Vol. 57 Issue 6

June 2004

Volume 57, Issue 6

Pages 693–831

  1. Editors’ View

    1. Top of page
    2. Editors’ View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics/Pharmacodynamics
    7. Pharmacogenetics
    8. Therapeutics
    9. Adverse Drug Reactions
    10. Short Reports
    11. Letter to the Editors
    12. Book Review
    1. You have free access to this content
  2. Review

    1. Top of page
    2. Editors’ View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics/Pharmacodynamics
    7. Pharmacogenetics
    8. Therapeutics
    9. Adverse Drug Reactions
    10. Short Reports
    11. Letter to the Editors
    12. Book Review
    1. You have free access to this content
      The revision of the Declaration of Helsinki: past, present and future (pages 695–713)

      Robert V. Carlson, Kenneth M. Boyd and David J. Webb

      Version of Record online: 21 APR 2004 | DOI: 10.1111/j.1365-2125.2004.02103.x

      • image
  3. Pharmacodynamics

    1. Top of page
    2. Editors’ View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics/Pharmacodynamics
    7. Pharmacogenetics
    8. Therapeutics
    9. Adverse Drug Reactions
    10. Short Reports
    11. Letter to the Editors
    12. Book Review
    1. You have free access to this content
    2. You have free access to this content
      Endothelins and their inhibition in the human skin microcirculation: ET[1−31], a new vasoconstrictor peptide (pages 720–725)

      Stephen J. Leslie, Mamun Q. Rahman, Martin A. Denvir, David E. Newby and David J. Webb

      Version of Record online: 22 APR 2004 | DOI: 10.1111/j.1365-2125.2004.02074.x

      • image
      • image
      • image
    3. You have free access to this content
      The calcimimetic agent KRN 1493 lowers plasma parathyroid hormone and ionized calcium concentrations in patients with chronic renal failure on haemodialysis both on the day of haemodialysis and on the day without haemodialysis (pages 726–734)

      Naro Ohashi, Toshihiko Uematsu, Satoru Nagashima, Mitsutaka Kanamaru, Akashi Togawa, Akira Hishida, Eiji Uchida, Tadao Akizawa and Shozo Koshikawa

      Version of Record online: 22 APR 2004 | DOI: 10.1111/j.1365-2125.2004.02088.x

      • image
      • image
      • image
      • image
      • image
      • image
  4. Pharmacokinetics

    1. Top of page
    2. Editors’ View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics/Pharmacodynamics
    7. Pharmacogenetics
    8. Therapeutics
    9. Adverse Drug Reactions
    10. Short Reports
    11. Letter to the Editors
    12. Book Review
    1. You have free access to this content
      Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis (pages 735–741)

      T. Trenque, N. Simon, I. Villena, C. Chemla, C. Quereux, B. Leroux, R. Jaussaud, G. Rémy, D. Dupouy, H. Millart, J.-M. Pinon and S. Urien

      Version of Record online: 23 MAR 2004 | DOI: 10.1111/j.1365-2125.2004.02077.x

      • image
      • image
      • image
    2. You have free access to this content
      Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients (pages 742–755)

      David J. R. Foster, Andrew A. Somogyi, Jason M. White and Felix Bochner

      Version of Record online: 21 APR 2004 | DOI: 10.1111/j.1365-2125.2004.02079.x

      • image
      • image
    3. You have free access to this content
    4. You have free access to this content
      Maximum a posteriori Bayesian estimation of epirubicin clearance by limited sampling (pages 764–772)

      Lorraine D. Ralph, Alison H. Thomson, Nicola A. Dobbs and Chris Twelves

      Version of Record online: 22 APR 2004 | DOI: 10.1111/j.1365-2125.2004.02084.x

      • image
      • image
      • image
  5. Pharmacokinetics/Pharmacodynamics

    1. Top of page
    2. Editors’ View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics/Pharmacodynamics
    7. Pharmacogenetics
    8. Therapeutics
    9. Adverse Drug Reactions
    10. Short Reports
    11. Letter to the Editors
    12. Book Review
    1. You have free access to this content
  6. Pharmacogenetics

    1. Top of page
    2. Editors’ View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics/Pharmacodynamics
    7. Pharmacogenetics
    8. Therapeutics
    9. Adverse Drug Reactions
    10. Short Reports
    11. Letter to the Editors
    12. Book Review
    1. You have free access to this content
      Relationship between Type A and B personality and debrisoquine hydroxylation capacity (pages 785–789)

      S. H. Gan, R. Ismail, W. A. Wan Adnan, W. Zulmi, N. Kumaraswamy and E. T. Larmie

      Version of Record online: 21 APR 2004 | DOI: 10.1111/j.1365-2125.2004.02076.x

      • image
      • image
  7. Therapeutics

    1. Top of page
    2. Editors’ View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics/Pharmacodynamics
    7. Pharmacogenetics
    8. Therapeutics
    9. Adverse Drug Reactions
    10. Short Reports
    11. Letter to the Editors
    12. Book Review
    1. You have free access to this content
      Leflunomide in active rheumatoid arthritis: a prospective study in daily practice (pages 790–797)

      E. N. Van Roon, T. L. TH. A. Jansen, L. Mourad, P. M. Houtman, G. A. W. Bruyn, E. N. Griep, B. Wilffert, H. Tobi and J. R. B. J. Brouwers

      Version of Record online: 23 MAR 2004 | DOI: 10.1111/j.1365-2125.2004.02075.x

      • image
      • image
    2. You have free access to this content
      Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study (pages 798–806)

      Dominique Deplanque, Didier Leys, Lucilla Parnetti, Reinhold Schmidt, Jose Ferro, Jacques De Reuck, Jean-Louis Mas, Virgilio Gallai and the SAFE ll Investigators

      Version of Record online: 22 APR 2004 | DOI: 10.1111/j.1365-2125.2004.02086.x

  8. Adverse Drug Reactions

    1. Top of page
    2. Editors’ View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics/Pharmacodynamics
    7. Pharmacogenetics
    8. Therapeutics
    9. Adverse Drug Reactions
    10. Short Reports
    11. Letter to the Editors
    12. Book Review
    1. You have free access to this content
      Subclinical alteration of taste sensitivity induced by candesartan in healthy subjects (pages 807–812)

      Shuichi Tsuruoka, Michi Wakaumi, Kenta Nishiki, Nobutaka Araki, Kenichi Harada, Koichi Sugimoto and Akio Fujimura

      Version of Record online: 21 APR 2004 | DOI: 10.1111/j.1365-2125.2003.02063.x

      • imageimageimageimage
      • image
      • image
      • image
      • image
  9. Short Reports

    1. Top of page
    2. Editors’ View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics/Pharmacodynamics
    7. Pharmacogenetics
    8. Therapeutics
    9. Adverse Drug Reactions
    10. Short Reports
    11. Letter to the Editors
    12. Book Review
    1. You have free access to this content
      Bisphosphonate use and subsequent prescription of acid suppressants (pages 813–816)

      E. E. Roughead, K. McGeechan and G. P. Sayer

      Version of Record online: 21 APR 2004 | DOI: 10.1111/j.1365-2125.2004.02078.x

  10. Letter to the Editors

    1. Top of page
    2. Editors’ View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics/Pharmacodynamics
    7. Pharmacogenetics
    8. Therapeutics
    9. Adverse Drug Reactions
    10. Short Reports
    11. Letter to the Editors
    12. Book Review
    1. You have free access to this content
    2. You have free access to this content
      Author's reply (page 817)

      NJ Langford, AM Good, WJ Laing and DN Bateman

      Version of Record online: 18 MAY 2004 | DOI: 10.1111/j.1365-2125.2004.02135.x

  11. Book Review

    1. Top of page
    2. Editors’ View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics/Pharmacodynamics
    7. Pharmacogenetics
    8. Therapeutics
    9. Adverse Drug Reactions
    10. Short Reports
    11. Letter to the Editors
    12. Book Review
    1. You have free access to this content
    2. You have free access to this content
      Announcements (page 819)

      Version of Record online: 18 MAY 2004 | DOI: 10.1111/j.1365-2125.2004.02165.x

    3. You have free access to this content
      Subject index (pages 830–831)

      Version of Record online: 18 MAY 2004 | DOI: 10.1111/j.1365-2125.2004.02167.x

    4. You have free access to this content
      Author index (pages 820–829)

      Version of Record online: 18 MAY 2004 | DOI: 10.1111/j.1365-2125.2004.02166.x

SEARCH

SEARCH BY CITATION